Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1766399

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1766399

Latin America Fabry Disease Treatment Market Size, Share, & Industry Analysis Report By Route of Administration (Intravenous Route and Oral Route), By Therapy, By Distribution Channel, By Country - Market Forecast, 2025-2034

PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The latin america fabry market size is expected to reach USD 164.68 million by 2034, according to a new study by Polaris Market Research. The report "Latin America Fabry Disease Treatment Market Size, Share, & Industry Analysis Report By Route of Administration (Intravenous Route and Oral Route), By Therapy, By Distribution Channel, By Country - Market Forecast, 2025-2034 - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Latin America Fabry disease treatment market is witnessing steady growth, supported by an evolving healthcare landscape and increased prioritization of rare diseases in public health agendas. Growing awareness among clinicians and patients about the genetic nature and progressive symptoms of Fabry disease is leading to earlier diagnosis and more timely therapeutic interventions. Major urban centers across countries such as Brazil, Mexico, and Argentina are expanding their specialty care infrastructure, including the establishment of metabolic disorder clinics equipped to administer enzyme replacement therapy (ERT) and other advanced modalities. Industry analysis highlights a shift toward more personalized and accessible treatment models, with market expansion strategies increasingly focused on collaborations between regional healthcare providers and multinational pharmaceutical firms.

Strategic alliances and joint ventures are enabling the introduction of next-generation oral therapies, while improvements in distribution networks and pricing strategies are helping to broaden patient access. The region also presents opportunities for technology advancements, especially in telehealth and home-based treatment monitoring, which are expected to enhance adherence and outcomes in the coming years.

Latin America Fabry Disease Treatment Market Report Highlights

By route of administration, in 2024, the intravenous route segment was valued at USD 129 million and dominated the market revenue share due to its continued role as the primary method of delivering enzyme replacement therapy for Fabry disease.

Based on therapy, in 2024, the enzyme replacement therapy (ERT) segment was valued at approximately USD 135 million. The segment led the market revenue share driven by its established clinical efficacy and long-standing use in Fabry disease management.

The Brazil Fabry disease treatment market accounts for approximately 40% of the total regional revenue. The market growth is largely attributed to a combination of advanced healthcare access in major cities and government support for rare disease initiatives.

The Argentina Fabry disease treatment market is projected to register a CAGR of 6.5% from 2025 to 2034, fueled by a rising focus on rare disease detection and enhanced collaboration between public healthcare bodies and global pharmaceutical developers.

A few key players include Amicus Therapeutics, Inc.; CANbridge Life Sciences Ltd.; Chiesi Farmaceutici S.p.A.; Idorsia Pharmaceuticals Ltd.; ISU ABXIS Co., Ltd.; JCR Pharmaceuticals Co., Ltd.; Protalix Biotherapeutics Inc.; Sangamo Therapeutics, Inc.; Sanofi; and Takeda Pharmaceutical.

Polaris Market Research has segmented the Latin America Fabry disease treatment market report on the basis of route of administration, therapy, distribution channel, and country:

By Route of Administration Outlook (Revenue USD Million, 2020-2034)

Intravenous Route

Oral Route

By Therapy Outlook (Revenue USD Million, 2020-2034)

Enzyme Replacement Therapy (ERT)

Substrate Reduction Therapy (SRT)

Others

By Distribution Channel Outlook (Revenue USD Million, 2020-2034)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country Outlook (Revenue USD Million, 2020-2034)

Brazil

Mexico

Argentina

Colombia

Chile

Peru

Ecuador

Paraguay

Rest of LATAM

Product Code: PM5773

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Latin America Fabry Disease Treatment Market Insights

  • 4.1. Latin America Fabry Disease Treatment Market - Market Snapshot
  • 4.2. Latin America Fabry Disease Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Awareness of Rare Diseases
      • 4.2.1.2. Growth in Urban Healthcare Infrastructure
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Shortage of Skilled Personal
  • 4.3. Porter Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Latin America Fabry Disease Treatment Market Trends
  • 4.6. Value Chain Analysis

5. Latin America Fabry Disease Treatment Market, by Route of Administration

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Latin America Fabry Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • 5.3. Intravenous Route
    • 5.3.1. Latin America Fabry Disease Treatment Market, by Intravenous Route, by Country, 2020-2034 (USD Million)
  • 5.4. Oral Route
    • 5.4.1. Latin America Fabry Disease Treatment Market, by Oral Route, by Country, 2020-2034 (USD Million)

6. Latin America Fabry Disease Treatment Market, by Therapy

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Latin America Fabry Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • 6.3. Enzyme Replacement Therapy (ERT)
    • 6.3.1. Latin America Fabry Disease Treatment Market, by Enzyme Replacement Therapy (ERT), by Country, 2020-2034 (USD Million)
  • 6.4. Substrate Reduction Therapy (SRT)
    • 6.4.1. Latin America Fabry Disease Treatment Market, by Substrate Reduction Therapy (SRT), by Country, 2020-2034 (USD Million)
  • 6.5. Others
    • 6.5.1. Latin America Fabry Disease Treatment Market, by Others, by Country, 2020-2034 (USD Million)

7. Latin America Fabry Disease Treatment Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Latin America Fabry Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Latin America Fabry Disease Treatment Market, by Hospital Pharmacies, by Country, 2020-2034 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Latin America Fabry Disease Treatment Market, by Retail Pharmacies, by Country, 2020-2034 (USD Million)
  • 7.5. Online Pharmacies
    • 7.5.1. Latin America Fabry Disease Treatment Market, by Online Pharmacies, by Country, 2020-2034 (USD Million)

8. Latin America Fabry Disease Treatment Market, by Country

  • 8.1. Key Findings
  • 8.2. Introduction
  • 8.3. Latin America Fabry Disease Treatment Market
    • 8.3.1. Latin America: Latin America Fabry Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.3.2. Latin America: Latin America Fabry Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
    • 8.3.3. Latin America: Latin America Fabry Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.4. Latin America Fabry Disease Treatment Market - Mexico
      • 8.3.4.1. Mexico: Latin America Fabry Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.3.4.2. Mexico: Latin America Fabry Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.3.4.3. Mexico: Latin America Fabry Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.5. Latin America Fabry Disease Treatment Market - Brazil
      • 8.3.5.1. Brazil: Latin America Fabry Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.3.5.2. Brazil: Latin America Fabry Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.3.5.3. Brazil: Latin America Fabry Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.6. Latin America Fabry Disease Treatment Market - Argentina
      • 8.3.6.1. Argentina: Latin America Fabry Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.3.6.2. Argentina: Latin America Fabry Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.3.6.3. Argentina: Latin America Fabry Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.7. Latin America Fabry Disease Treatment Market - Rest of Latin America
      • 8.3.7.1. Rest of Latin America: Latin America Fabry Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.3.7.2. Rest of Latin America: Latin America Fabry Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.3.7.3. Rest of Latin America: Latin America Fabry Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Amicus Therapeutics, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. CANbridge Life Sciences Ltd.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Chiesi Farmaceutici S.p.A.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Idorsia Pharmaceuticals Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. ISU ABXIS Co., Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. JCR Pharmaceuticals Co., Ltd.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Protalix Biotherapeutics Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Sangamo Therapeutics, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sanofi
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Takeda Pharmaceutical
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
Product Code: PM5773

List of Tables:

  • Table 1 Latin America: Latin America Fabry Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 2 Latin America: Latin America Fabry Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 3 Latin America: Latin America Fabry Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 4 Mexico: Latin America Fabry Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 5 Mexico: Latin America Fabry Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 6 Mexico: Latin America Fabry Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 7 Brazil: Latin America Fabry Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 8 Brazil: Latin America Fabry Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 9 Brazil: Latin America Fabry Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 10 Argentina: Latin America Fabry Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 11 Argentina: Latin America Fabry Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 12 Argentina: Latin America Fabry Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 13 Rest of Latin America: Latin America Fabry Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 14 Rest of Latin America: Latin America Fabry Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 15 Rest of Latin America: Latin America Fabry Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Latin America Fabry Disease Treatment Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Country
  • Figure 5. Porter Five Forces
  • Figure 6. Market by Route of Administration
  • Figure 7. Latin America Fabry Disease Treatment Market, by Route of Administration, 2024 & 2034 (USD Million)
  • Figure 8. Market by Therapy
  • Figure 9. Latin America Fabry Disease Treatment Market, by Therapy, 2024 & 2034 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Latin America Fabry Disease Treatment Market, by Distribution Channel, 2024 & 2034 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!